Researchers examine signal necrotic cells that prompt phagocytic cells to overwhelm the dying cell Kumar Jeetendra | May 8, 2021 As people keep their homes clean and clutter in check, a crew of cells within the body is in charge of clearing the waste that the body generates, including cells that are dying. The housekeeping cells remove unwanted material by a process called phagocytosis, which literally means’eating cells’ “Phagocytosis is quite important for the body’s …
A solitary archaeal compound can create a spectacular scope of regular and non-common cardiolipins Kumar Jeetendra | May 7, 2021 Cells of all life forms are surrounded by a membrane that’s made of phospholipids. One of them are the cardiolipins, which form another class due to their distinctive structure. When studying the enzyme that’s responsible for generating cardiolipins in archaea (single-cell organisms that constitute a separate domain of life), biochemists at the University of Groningen …
DRDO Centre for Artificial Intelligence and Robotics, with the support of 5C Network & HCG Academics develops ‘Atman AI’ for COVID detection in Chest X-rays Kumar Jeetendra | May 7, 2021 Bangalore 7th May 2021: DRDO Centre for Artificial Intelligence and Robotics, with the support of 5C Network & HCG Academics has developed “ATMAN AI”, an Artificial Intelligence algorithm that can detect the presence of COVID-19 disease in Chest X Rays. The ATMAN AI is an artificial intelligence tool for Chest X-ray screening as triaging tool …
NEC contributes to development of artificial DNA aptamer that binds to the novel coronavirus (SARS-CoV-2) Kumar Jeetendra | May 6, 2021 India, May 6, 2021 – NEC Corporation (NEC; TSE: 6701) and NEC Solution Innovators today announced the successful development of artificial DNA aptamers (*1) that bind to the novel coronavirus (SARS-CoV-2). This breakthrough stems from the NEC Group’s efforts to promote spatial monitoring business using aptamers, including the development of new biosensing systems, such as …
Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail used in the treatment of Covid-19 Kumar Jeetendra | May 5, 2021 Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19 Casirivimab and Imdevimab is indicated for the treatment of mild to moderate Covid-19 in high-risk patients Partners with Cipla for pan-India distribution At a global level, Roche and its partner Regeneron are collaborating to …
Researchers grow better approach to screen electrostatic signs radiated by honeybees Kumar Jeetendra | May 5, 2021 Honeybees have a complex communication system. Between buzzes and body movements, they can direct hive mates to food sources, signal danger, and prepare for swarming – all indicators of colony health. And today, researchers are listening in. Scientists based in Germany – with collaborators in China and Norway – have developed a way to monitor …
Critical care attendants in poor physical and mental wellness report more medical errors Kumar Jeetendra | May 4, 2021 A study led by The Ohio State University College of Nursing finds that critical care nurses in poor physical and mental health reported significantly more medical errors than nurses in better health. The analysis, which was conducted prior to the COVID-19 pandemic, also found that”nurses who perceived their worksite was very supportive of the well-being …
Practo aims to vaccinate over one crore Indians as part of ‘Corporate Suraksha’ program Kumar Jeetendra | May 3, 2021 Bengaluru, May 3, 2021: As India battles a deadly second wave of COVID-19 and the need for immunization intensifies, Practo today announced ‘Corporate Suraksha’, a corporate vaccination program for companies across the country. The registrations are now open (https://www.partnership.practo.com/suraksha) for corporates to enlist their employees and their family members for the inoculation. Additionally, corporates can …
Antiviral T cells protected, viable as off-the-shelf treatment for painful complication stem cells Kumar Jeetendra | May 2, 2021 Infusion of T cells targeting BKV resulted in rapid responses, with 67.7% of patients seeing a complete or partial improvement in symptoms after 14 days. This increased to 81.6% of patients after 28 days post-infusion. No cases of grade 3 or grade 4 graft versus host disease (GVHD) or other infusion-related toxicities occurred. Addressing a …
Novel technique gives quicker and more exact diagnostics in histopathology Kumar Jeetendra | May 1, 2021 Histology is the study of biological cells at a microscopic level. Also called microscopic anatomy, histology is widely used to offer identification of cancer and other diseases. For instance, tissue samples obtained during surgery might help to ascertain whether additional surgical action is needed, and additional surgery may be avoided if a diagnosis can be …
New hereditarily encoded sensor recognizes drugs of abuse Kumar Jeetendra | April 29, 2021 A genetically encoded sensor to detect hallucinogenic compounds has been developed by researchers at the University of California, Davis. Named psychLight, the sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse. The work is published April 28 in the journal Cell. Compounds associated with …
J Mitra Launches India’s First Covid-19 Neutralizing Antibody Test Kumar Jeetendra | April 29, 2021 New Delhi, 29th April 2021: J Mitra & Company, the global leader in the IVD space, has launched India’s first Covid-19 Neutralizing Antibody Microlisa Elisa Test its ongoing fight against the corona pandemic. The test kit has cleared all government parameters and received all necessary approvals, including Drug Controller General of India (DCGI) & successful …
